Herpes simplex virus type 2 seroprevalence and associated factors in fertility-treatment-seeking population: A cross-sectional survey in the United Arab Emirates.
fertility
genital infections
herpes simplex virus type 2 (HSV-2)
infertility
pregnancy
reproductive health
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2022
2022
Historique:
received:
11
07
2022
accepted:
29
09
2022
entrez:
24
11
2022
pubmed:
25
11
2022
medline:
26
11
2022
Statut:
epublish
Résumé
Herpes simplex virus type 2 (HSV-2) is a common genitally-transmitted viral infection affecting more than 400 million individuals globally. In the United Arab Emirates (UAE), in specific at-risk population groups, the burden of HSV-2 has not been reported. This study investigated the prevalence of HSV-2 IgG antibodies in patients seeking fertility treatment and characterized patients with seropositivity to HSV-2 IgG antibodies. A cross-sectional sample of patients seeking fertility treatment in a major fertility clinic in Abu Dhabi, UAE was surveyed from April to May 2021. Patients were consecutively invited to complete self-administered questionnaires and provide blood for HSV-2 testing. Information on sociodemographics, medical history, and infertility was collected. Serum specimens were screened using an enzyme-linked immunosorbent assay for HSV-2 IgG antibodies detection. Two hundred and ninety-nine patients were surveyed and provided blood samples. The mean age of the patients was 35.9 ± 6.8 [mean ± standard deviation (SD)] years with 89.3% being women. Sixty-six percent were overweight or obese, 25.0% had at least one chronic comorbidity, and 19.6% reported ever-had genital infection. More than two-thirds (68.3%) of the patients were infertile for ≥ 6 months. Of the 42 infertile males, 69.0% had an abnormal semen analysis. HSV-2 IgG antibodies was detected in 12.4% of patients. The HSV-2 IgG seropositive patients had a higher mean age (39.5 vs. 35.4 years; p < 0.001) compared to seronegative patients. HSV-2 IgG antibodies seropositivity was more common in males (15.6%) than females (12.0%), in patients with secondary (14.1%) vs. primary (9.2%) infertility, or in males with abnormal (10.3%) vs. normal (7.7%) semen. Exposure to HSV-2 at any time in patients seeking fertility treatment in the UAE was found to be slightly common in more than one out of 10 patients. Tailored health campaigns on HSV-2 prevention are warranted.
Sections du résumé
Background
Herpes simplex virus type 2 (HSV-2) is a common genitally-transmitted viral infection affecting more than 400 million individuals globally. In the United Arab Emirates (UAE), in specific at-risk population groups, the burden of HSV-2 has not been reported. This study investigated the prevalence of HSV-2 IgG antibodies in patients seeking fertility treatment and characterized patients with seropositivity to HSV-2 IgG antibodies.
Methodology
A cross-sectional sample of patients seeking fertility treatment in a major fertility clinic in Abu Dhabi, UAE was surveyed from April to May 2021. Patients were consecutively invited to complete self-administered questionnaires and provide blood for HSV-2 testing. Information on sociodemographics, medical history, and infertility was collected. Serum specimens were screened using an enzyme-linked immunosorbent assay for HSV-2 IgG antibodies detection.
Results
Two hundred and ninety-nine patients were surveyed and provided blood samples. The mean age of the patients was 35.9 ± 6.8 [mean ± standard deviation (SD)] years with 89.3% being women. Sixty-six percent were overweight or obese, 25.0% had at least one chronic comorbidity, and 19.6% reported ever-had genital infection. More than two-thirds (68.3%) of the patients were infertile for ≥ 6 months. Of the 42 infertile males, 69.0% had an abnormal semen analysis. HSV-2 IgG antibodies was detected in 12.4% of patients. The HSV-2 IgG seropositive patients had a higher mean age (39.5 vs. 35.4 years; p < 0.001) compared to seronegative patients. HSV-2 IgG antibodies seropositivity was more common in males (15.6%) than females (12.0%), in patients with secondary (14.1%) vs. primary (9.2%) infertility, or in males with abnormal (10.3%) vs. normal (7.7%) semen.
Conclusion
Exposure to HSV-2 at any time in patients seeking fertility treatment in the UAE was found to be slightly common in more than one out of 10 patients. Tailored health campaigns on HSV-2 prevention are warranted.
Identifiants
pubmed: 36420003
doi: 10.3389/fpubh.2022.991040
pmc: PMC9677722
doi:
Substances chimiques
Antibodies, Viral
0
Immunoglobulin G
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
991040Informations de copyright
Copyright © 2022 Abdo, Aslam, Irfan, George, Alsuwaidi, Ahmed and Al-Rifai.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
PLoS One. 2015 Jan 21;10(1):e114989
pubmed: 25608026
BMJ Glob Health. 2020 Mar 8;5(3):e001875
pubmed: 32201620
Adv Exp Med Biol. 2011;697:221-30
pubmed: 21120729
J Adolesc Health. 2019 Dec;65(6):723-729
pubmed: 31521513
Sex Transm Infect. 2006 Apr;82(2):159-63
pubmed: 16581747
Congenit Anom (Kyoto). 2022 Mar;62(2):54-67
pubmed: 34961973
J Biomed Res. 2013 Jan;27(1):56-61
pubmed: 23554795
Acta Microbiol Immunol Hung. 2008 Dec;55(4):429-36
pubmed: 19130750
Nat Rev Urol. 2014 Dec;11(12):672-87
pubmed: 25330794
Herpes. 2004 Aug;11 Suppl 3:175A-186A
pubmed: 15319088
Clin Infect Dis. 2013 Feb;56(3):344-51
pubmed: 23087395
Lancet Infect Dis. 2017 Dec;17(12):1303-1316
pubmed: 28843576
Medicina (Kaunas). 2021 Aug 24;57(9):
pubmed: 34577786
BMC Infect Dis. 2019 May 6;19(1):382
pubmed: 31060582
Indian J Med Res. 2011 Oct;134:440-6
pubmed: 22089604
Hum Reprod. 2010 Oct;25(10):2507-15
pubmed: 20685757
Interdiscip Perspect Infect Dis. 2014;2014:347602
pubmed: 24982675
Clin Diagn Lab Immunol. 2005 Feb;12(2):359-60
pubmed: 15699434
Am J Obstet Gynecol. 2017 Jan;216(1):1-9
pubmed: 28007229
Urology. 2018 Mar;113:52-58
pubmed: 29287977
Indian J Sex Transm Dis AIDS. 2010 Jan;31(1):11-5
pubmed: 21808430
Obstet Gynecol. 1996 Apr;87(4):483-8
pubmed: 8602295
Andrologia. 2018 Jan 1;:
pubmed: 29292525
Sex Transm Dis. 2015 Sep;42(9):526-32
pubmed: 26267880
Int J STD AIDS. 2022 Mar;33(3):304-310
pubmed: 34978219